News & Updates

COVID-19 vaccines highly effective against hospitalization, ICU admission

14 Sep 2021 by

A US study has found that COVID-19 vaccines are very effective at preventing SARS-CoV-2 infection requiring hospitalization, intensive care unit (ICU) admission, or an emergency department (ED) or urgent care clinic visit among adults aged ≥50 years, including those most at risk for severe disease due to advanced age, comorbidities, or race/ethnicity.

COVID-19 vaccines highly effective against hospitalization, ICU admission

14 Sep 2021

Vonoprazan-based regimen shows treatment potential against H. pylori

14 Sep 2021 by

A 14-day quadruple therapeutic regimen containing vonoprazan – a first-in-class potassium-competitive acid blocker (P-CAB) with reportedly stronger acid inhibition than proton pump inhibitors – provided an excellent cure rate for Helicobacter pylori (H. pylori) infection in patients with high clarithromycin and quinolone resistance regardless of CYP3A4/5 genotypic polymorphism, according to the prospective VQ-HP trial presented at APDW 2021.

Vonoprazan-based regimen shows treatment potential against H. pylori

14 Sep 2021

Metoprolol safe, eases lung inflammation in critically ill COVID-19 patients

13 Sep 2021 by

Intravenous (IV) administration of the beta-blocker metoprolol safely reduces the exacerbation of lung in patients with COVID-19–related acute respiratory distress syndrome (ARDS), a study has shown. Reduced lung inflammation then leads to improvement in oxygenation and to fewer days on mechanical ventilation and of admission to intensive care unit (ICU).

Metoprolol safe, eases lung inflammation in critically ill COVID-19 patients

13 Sep 2021

Does PPI use affect clinical outcomes in COVID-19 patients?

13 Sep 2021 by

According to a Hong Kong study presented at APDW 2021, the use of proton pump inhibitors (PPIs) is not associated with adverse clinical outcomes in individuals with COVID-19.

Does PPI use affect clinical outcomes in COVID-19 patients?

13 Sep 2021

Same-day ART tied to suboptimal 12-month viral suppression

12 Sep 2021

Patients who initiate antiretroviral therapy (ART) on the same day as their HIV diagnosis achieve suboptimal levels of viral load suppression by 12 months, a recent study has found. Such a trend emphasizes the importance of reinforcing treatment adherence among patients.

Same-day ART tied to suboptimal 12-month viral suppression

12 Sep 2021

Prophylactic rivaroxaban improves clinical outcomes in discharged COVID-19 patients

10 Sep 2021 by

In individuals who were discharged following hospitalization due to COVID-19, thromboprophylaxis with the novel oral anticoagulant rivaroxaban for 35 days led to improved clinical outcomes without increased bleeding compared with no anticoagulation post-discharge, according to findings from the MICHELLE* trial.

Prophylactic rivaroxaban improves clinical outcomes in discharged COVID-19 patients

10 Sep 2021

Antibiotic exposure tied to increased early-onset CRC risk

09 Sep 2021 by

Antibiotic exposure may be associated with an increased risk of early-onset colorectal cancer (CRC), according to a study from Scotland presented at ESMO GI 2021.

Antibiotic exposure tied to increased early-onset CRC risk

09 Sep 2021

COVID-19 vaccines elicit weaker antibody response in multiple myeloma patients

09 Sep 2021

Patients with myeloma mount a neutered humoral immune response following vaccination for the coronavirus disease 2019 (COVID-19), especially when receiving antibody therapy, a recent study has found.

COVID-19 vaccines elicit weaker antibody response in multiple myeloma patients

09 Sep 2021

Delta doubles risk of severe COVID-19 among the unvaccinated

09 Sep 2021 by

The risk of hospitalization is more than doubled in patients infected with the Delta variant vs the Alpha variant, in particular among people who were unvaccinated, reveals a large cohort study — sounding the alarm that Delta is not only more transmissible, but also more virulent.

Delta doubles risk of severe COVID-19 among the unvaccinated

09 Sep 2021

Southeast Asia’s gastroenterologists buckle under heavy burnout burden amid COVID-19

09 Sep 2021 by

During the coronavirus disease 2019 (COVID-19) pandemic, burnout has become prevalent among gastroenterologists in Southeast Asia, driven strongly by fears of getting infected and the stress of reduced income, according to a Singapore study presented at the recently concluded Asian Pacific Digestive Week 2021 (APDW 2021).

Southeast Asia’s gastroenterologists buckle under heavy burnout burden amid COVID-19

09 Sep 2021

News & Updates

Filter by Specialty:

Specialty:

COVID-19 vaccines highly effective against hospitalization, ICU admission

COVID-19 vaccines highly effective against hospitalization, ICU admission

Vonoprazan-based regimen shows treatment potential against H. pylori

Vonoprazan-based regimen shows treatment potential against H. pylori

Metoprolol safe, eases lung inflammation in critically ill COVID-19 patients

Metoprolol safe, eases lung inflammation in critically ill COVID-19 patients

Does PPI use affect clinical outcomes in COVID-19 patients?

Does PPI use affect clinical outcomes in COVID-19 patients?

Same-day ART tied to suboptimal 12-month viral suppression

Same-day ART tied to suboptimal 12-month viral suppression

Prophylactic rivaroxaban improves clinical outcomes in discharged COVID-19 patients

Prophylactic rivaroxaban improves clinical outcomes in discharged COVID-19 patients

Antibiotic exposure tied to increased early-onset CRC risk

Antibiotic exposure tied to increased early-onset CRC risk

COVID-19 vaccines elicit weaker antibody response in multiple myeloma patients

COVID-19 vaccines elicit weaker antibody response in multiple myeloma patients

Delta doubles risk of severe COVID-19 among the unvaccinated

Delta doubles risk of severe COVID-19 among the unvaccinated

Southeast Asia’s gastroenterologists buckle under heavy burnout burden amid COVID-19

Southeast Asia’s gastroenterologists buckle under heavy burnout burden amid COVID-19